SCHEMBL5898573

SCHEMBL5898573

CCC(O)(C(N)=O)c1ccc(Br)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGG1 O15527 1/20 0.41
SCN5A Q14524 3/20 0.39
SCN9A Q15858 3/20 0.39
KIF11 P52732 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
HDAC3 O15379 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC2 Q92769 2/20 0.38
KMT2A Q03164 4/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 1/20 0.37
POLB P06746 1/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
EPHX1 P07099 1/20 0.37
GAA P10253 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NCOR2 Q9Y618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5898552 0.83 SCN5A (0.48) SCN5ASCN9AKIF11SMN1; SMN2KMT2A
SCHEMBL13946506 0.82 MAPT (0.55) SCN5ASCN9AKIF11KMT2AMAPT
SCHEMBL13946510 0.82 MAPT (0.55) SCN5ASCN9AKIF11KMT2AMAPT
SCHEMBL3837958 0.82 MAPT (0.55) SCN5ASCN9AKIF11KMT2AMAPT
SCHEMBL8356496 0.81 KCNN4 (0.55) SCN5ASCN9AKIF11SMN1; SMN2KMT2A
SCHEMBL8360666 0.81 SCN5A (0.49) SCN5ASCN9AKMT2AMEN1MAPT
SCHEMBL5898532 0.81 CES2 (0.44) SCN5ASCN9AKIF11KMT2AMEN1
SCHEMBL1141842 0.79 OGG1 (0.42) OGG1KIF11SMN1; SMN2HDAC3HDAC1
SCHEMBL6222218 0.78 OGG1 (0.41) OGG1KIF11SMN1; SMN2HDAC3HDAC1
SCHEMBL5898523 0.75 SMN1; SMN2 (0.40) OGG1KIF11SMN1; SMN2HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity MEZA TOLEDO SERGIO E 2006-12-21 US disclosed
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity MEZA TOLEDO SERGIO E 2006-12-21 US disclosed
WO-2003091201-A1 DL-HYDROXY-ALKYL-PHENYLAMIDES HAVING ANTICONVULSIVE ACTIVITY MEZA TOLEDO SERGIO ENRIQUE (MX) 2003-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity GABRB2, HRH3, HRH4 OGG1 4127/4885SCN5A 338/4885SCN9A 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.